FIELD: chemistry.
SUBSTANCE: invention relates to the field of organic chemistry, namely to derivatives of diaza-spiro[4.5]decan-1-one of formula (I) or to their pharmaceutically acceptable salts, where. R1 is a substituted phenyl, which contains one substituent, selected from the group, including C1-4-alkyl, C3-6-cycloalkyl halo-C1-4-alkyl and halo -C1-4-alkoxy, and which can additionally contain one substituent, selected from a halogen; R2 is hydrogen, C1-4-alkyl, phenyl, substituted phenyl, with the substituted phenyl containing one substituent, selected from the group, including C1-4-alkoxy; R3 is -R4, -C(OH)R5R6 or -C(O)NR7R8; R4 is phenyl, phenyl-C1-4-alkyl, substituted phenyl, substituted phenylcarbonyl, with the substituted phenyl, substituted phenylcarbonyl containing from one to two substituents, selected from the group, including a halogen, halo-C1-4-alkyl; one of R5 and R6 is hydrogen, C1-4-alkyl, and the other is aminocarbonyl, phenyl, substituted phenyl or substituted phenyl-C1-4-alkyl, with the substituted phenyl or substituted phenyl-C1-4-alkyl containing from one to two substituents, independently selected from the group, including a halogen; one of R7 and R8 is hydrogen C1-4-alkyl, and the other is C1-4-alkyl, C3-6-cycloalkyl, C1-4-alkoxy-C1-4-alkyl, phenyl-C1-4-alkyl, substituted phenyl or substituted phenyl-C1-4-alkyl, with the substituted phenyl or substituted phenyl-C1-4-alkyl containing one substituent, selected from the group, including a halogen, halo-C1-4-alkyl; or R7 and R8 together with a nitrogen atom, which they are bound to, form pyrrolidinyl; n equals zero or 1/ The invention also relates to a pharmaceutical composition based on the compound of formula (I), application of the formula (I) compound and a method of treatment.
EFFECT: obtained are novel heterocyclic compounds, useful as an inhibitor of hormone-sensitive lipase.
17 cl, 57 ex
Title | Year | Author | Number |
---|---|---|---|
NEW AZACYCLIC COMPOUNDS | 2011 |
|
RU2603263C2 |
2,8-DIAZASPIRO[4,5]DECAN-1-ONE DERIVATIVES, USEFUL AS INHIBITORS OF HORMONE-SENSITIVE LIPASE (HSL) | 2011 |
|
RU2606513C2 |
IMIDAZOLONE AND IMIDAZOLIDINONE DERIVATIVES AS 11B-HSD1 INHIBITORS FOR DIABETES | 2007 |
|
RU2439062C2 |
SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS INHIBITORS OF HSL, EFFECTIVE FOR DIABETES TREATMENT | 2010 |
|
RU2607080C2 |
INDOL-3-YL-CARBONYL-ASASPIRO DERIVATIVES AS VASOPRESSIN RECEPTOR ANTAGONISTS | 2006 |
|
RU2418801C2 |
AZACYCLIC SPIRODERIVATIVES AS HSL INHIBITORS | 2011 |
|
RU2567395C2 |
CYCLIC CYANOENONE DERIVATIVES AS KEAP1 MODULATORS | 2021 |
|
RU2822828C1 |
HETEROCYCLIC COMPOUND | 2019 |
|
RU2815003C2 |
SPIRO CONDENSED PYRROLIDINE DERIVATIVES AS INHIBITORS OF DEUBIQUITINATING ENZYMES (DUB) | 2017 |
|
RU2730552C2 |
HYDROXYPURINE COMPOUNDS AND WAYS OF THEIR USE | 2015 |
|
RU2673458C1 |
Authors
Dates
2015-05-10—Published
2010-11-26—Filed